Safety of low-dose brachytherapy for the treatment of oral cancer
Dion Smyth Lecturer-practitioner, Cancer and palliative care at Birmingham City University
Low-dose-rate brachytherapy (LDR-BT) for T1-2N0M0 oral cancers is a safe treatment, regardless of the presence of severe comorbidities, analysis of the records of 180 patients in Japan has found.
Cancer Nursing Practice.
11, 1, 13-13.
doi: 10.7748/cnp.11.1.13.s9
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
